Aspirin for Primary Cardiovascular Prevention: Assessing the Pros and Cons

https://www.jwatch.org/na49465/2019/07/12/aspirin-primary-cardiovascular-prevention-assessing-pros

Estimates from a meta-analysis suggest that the risks outweigh the benefits for most primary prevention patients.

Ryan
Ryan

No Comments

Write a Reply or Comment